Article Information
History
- August 2, 2021.
Article Versions
- You are currently viewing Version 1 of this article (August 2, 2021 - 09:04).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Julia Greissl*,a,
- Mitch Pesesky*,b,
- Sudeb C. Dalaib,c,
- Alison W. Rebmand,
- Mark J. Soloskid,
- Elizabeth J. Horne,
- Jennifer N. Dinesb,
- Rachel M. Gittelmanb,
- Thomas M. Snyderb,
- Ryan O. Emersonb,
- Edward Meedsa,
- Thomas Manleyb,
- Ian M. Kaplanb,
- Lance Baldob,
- Jonathan M. Carlson†,a,
- Harlan S. Robins†,b and
- John N. Aucott†,d,#
- aMicrosoft Research, Redmond, Washington, USA, and Cambridge, UK
- bAdaptive Biotechnologies, Seattle, Washington, USA
- cStanford University School of Medicine, Stanford, California, USA
- dLyme Disease Research Center, Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
- eLyme Disease Biobank, Portland, Oregon, USA
- ↵#Corresponding author: John N. Aucott, MD Lyme Disease Research Center The Johns Hopkins University 2360 W. Joppa Road Lutherville, MD, USA 21093 Tel: 410-616-7596 Fax: 410-367-2371 Email: jaucott2{at}jhmi.edu
Posted August 02, 2021.
Immunosequencing of the T-cell receptor repertoire reveals signatures specific for diagnosis and characterization of early Lyme disease
